[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sanofi
Sanofi stock sees mixed reactions as some posts highlight potential gains while others point to market volatility. Investors are watching closely as the stock navigates recent fluctuations and social engagement increases slightly.
About Sanofi
Sanofi (SNY) is a multinational pharmaceutical and healthcare company.
Insights #
- Sanofi sentiment is up XXXXX% from the previous week.
- Sanofi posts created is up XXX% from the previous week.
Price: $ #
Price 24-Hour Time-Series Raw Data
The price action is likely influenced by a combination of positive sentiment from potential gains and the volatility of the market, as indicated by the recent posts.
1-Year High: $XXXXXX on 2025-03-06
1-Year Low: $XXXXX on 2025-09-25
AltRank: undefined #
AltRank 24-Hour Time-Series Raw Data
Sanofi is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXX
1-Year High: XXXXX on 2025-03-17
1-Year Low: XXX on 2025-03-21
Galaxy Score: XX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-03-17
1-Year Low: XX on 2025-08-06
Engagements: XXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Week: XXXXX -XX%
1 Month: XXXXX +930%
6 Months: XXXXXX +452%
1 Year: XXXXXX +204%
1-Year High: XXXXX on 2025-10-07
1-Year Low: X on 2024-10-25
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
6 Months: XX +26%
1 Year: XX +138%
1-Year High: XX on 2025-03-05
1-Year Low: X on 2024-10-27
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Sanofi in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
6 Months: XX +83%
1 Year: XX +148%
1-Year High: XX on 2025-05-30
1-Year Low: X on 2024-10-27
The most influential creators that mention Sanofi in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Alpha_Bronze | X | XXXXX | X | X |
Sentiment: % #
Sentiment 24-Hour Time-Series Raw Data
Current Value: %
Daily Average: XX%
1 Week: XX% +8%
1 Month: XX% -XX%
6 Months: XX% +13%
1 Year: XX% +30%
1-Year High: XXX% on 2025-02-06
1-Year Low: XX% on 2025-06-02
Market Cap: $undefined #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2025-03-06
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-16
Top assets mentioned In the posts about Sanofi in the last XX hours
Sanofi (SNY) Synthetify (SNY) Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Eli Lilly and Company (LLY)
Top topics mentioned In the posts about Sanofi in the last XX hours
stocks healthcare, sanofi, $sny, canadian, investment, targets, iii, $edenpa, $cappa, $ripa, herms, $rmspa, $novo, $nvo, eli lilly, $lly, longterm, stocks, $mcpa, $stmpapa
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$SAN.PA: Sanofi is transforming into a focused biopharma powerhouse prioritizing long-term innovation over short-term margins. Dupixents sustained double-digit growth and a robust late-stage pipeline show strong future promise. Shares trade at a steep discount to peers despite resilient financials. Could Sanofis coming strategic moves unlock significant value for investors"
X Link @SentinelFlash 2025-10-15T03:49Z XXX followers, XX engagements
"$NOVO remains the cheapest WIDE MOAT among peers according to MS: $NVO price/fair value = XXXX $LLY XXXX $AZN XXXX $SAN.PA XXXX (NARROW) They consider the akero acquisition as accretive (good combination with GLP-1)"
X Link @JomaSilva88 2025-10-12T12:21Z XXX followers, 1221 engagements
"🎯 Picks achat/vente 💚 Zone favorable (sous rserve de bons fondamentaux) EDENRED $EDEN.PA CAPGEMINI $CAP.PA PERNOD RICARD $RI.PA HERMS INTERNATIONAL $RMS.PA DASSAULT SYSTMES $DSY.PA LVMH $MC.PA L'ORAL $OR.PA TELEPERFORMANCE $TEP.PA STELLANTIS $STLAP.PA STMICROELECTRONICS $STMPA.PA SANOFI $SAN.PA AIR LIQUIDE $AI.PA 🟰 Zone Neutre KERING $KER.PA MICHELIN $ML.PA TOTALENERGIES $TTE.PA EUROFINS SCIENTIFIC $ERF.PA VEOLIA ENVIRONNEMENT $VIE.PA CARREFOUR $CA.PA VINCI $DG.PA SCHNEIDER ELECTRIC $SU.PA PUBLICIS GROUPE $PUB.PA RENAULT $RNO.PA ARCELORMITTAL $MT.AS SAINT-GOBAIN $SGO.PA ACCOR $AC.PA 🚨"
X Link @AssetControlPro 2025-10-11T15:03Z 3736 followers, XXX engagements
"Sanofis Orano Med-partnered radioligand therapy AlphaMedix achieved all primary efficacy endpoints Including a measure of overall response rate in the mid-stage ALPHAMEDIX-02 study $SNY $SAN.PA #pharma #radiopharmaceuticals"
X Link @Alpha_Bronze 2025-10-09T14:25Z 7556 followers, XX engagements